LFCR
Lifecore Biomedical, Inc.
Healthcare — Drug Manufacturers - Specialty & Generic
Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization that serves customers in the United States, Belgium, the Netherlands, and internationally. It provides services in the development, manufacture, aseptic fill, and finish of formulations and highly viscous sterile injectable pharmaceutical drug or medical device products in syringes, vials, and cartridges in various modalities. The company also manufactures and sells pharmaceutical-grade hyaluronic acid in bulk form, as well as for use in formulated and filled syringes and vials for injectable products used in treating various medical conditions and procedures, including ophthalmic and orthopedic applications. In addition, it offers product development services, including analytical method development and validation, formulation development, sterile filtration, process scale-up, pilot studies, stability studies, process validation, and materials production for clinical studies. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was founded in 1965 and is headquartered in Chaska, Minnesota.
Price History
Fundamentals
| Market Cap | $165.79M |
| P/E Ratio (TTM) | - |
| Forward P/E | -5.39 |
| EPS (TTM) | $-1.27 |
| Dividend Yield | - |
| Profit Margin | -23.78% |
| Revenue Growth | - |
| ROE | - |
| Debt/Equity | 722.60 |
| Recommendation | Buy 2.0 |
| Analyst Target | $6.83 |
| Analysts | 3 |
| Next Earnings | Aug 5, 2026 BMO |
| Indexes | - |
Technical Indicators
| RSI (14) | 41.5 |
| Beta | 1.06 |
| SMA 20 | $4.61 |
| SMA 40 | $5.05 |
| 52-Week High | $8.98 |
| 52-Week Low | $3.63 |
| 50-Day Avg | $5.04 |
| 200-Day Avg | $6.24 |
| Avg Volume | 197.8K |
| Volume | 77.8K |
Performance Analysis
BULLISHLFCR shows predominantly bullish signals based on its fundamentals and technicals.
Recent News
Last updated: Aug 01, 2026 04:15 UTC
Back to Screener Export Report